Skip to main content
. 2019 Sep 6;30(10):1991–1999. doi: 10.1681/ASN.2018101037

Table 3.

Estimation of annual public direct medical cost by disease status at baseline

Disease Status at Baseline Average public direct medical cost (US$±SD) Multiplier (95% CI)
Age and Sex Age, Sex, and Smoking Age, Sex, Smoking, and Intermediate Risk Factorsa Age, Sex, Smoking, Intermediate Risk Factors, Diagnosis of Diabetes, and Medicationsb
No CVD or moderate/severe CKD 1709±6989 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
Heart diseases 4335±11,119 1.55 (1.49,1.61) 1.55 (1.49,1.62) 1.49 (1.43,1.54) 1.53 (1.47,1.59)
Stroke 4146±12,464 1.66 (1.60,1.72) 1.65 (1.60,1.71) 1.61 (1.55,1.67) 1.66 (1.60,1.72)
Moderate CKD 5048±12,903 1.89 (1.82,1.97) 1.89 (1.81,1.96) 1.83 (1.76,1.90) 1.80 (1.73,1.87)
Severe CKD 9346±16,042 4.16 (3.59,4.82) 4.14 (3.57,4.80) 3.95 (3.41,4.58) 3.87 (3.34,4.47)

Heart diseases include coronary heart disease and heart failure. Moderate CKD, eGFR 30–59 ml/min per 1.73 m2; severe CKD, eGFR 15–29 ml/min per 1.73 m2. The P values for all multiplier were <0.001 by generalized linear model with γ family and log link function. CI, confidence interval; CVD, cardiovascular disease.

a

Intermediate risk factors include systolic and diastolic BP, LDL cholesterol, body mass index, total cholesterol/HDL ratio, triglycerides, and fasting glucose at baseline.

b

Diagnosis of diabetes and medications include number of antihypertensive drugs used, use of antidiabetic drugs, and lipid-lowering drugs at baseline.